C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Market Cap

C4 Therapeutics has a market cap or net worth of $389.44 million as of May 17, 2024. Its market cap has increased by 135.60% in one year.

• Market Cap: 389.44M
• Enterprise Value: 197.53M
• 1-Year Change: 135.60%
• Ranking: #3171
• Category: Small-Cap
• Stock Price: $5.68

Market Cap Chart

Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $389.44M, a decrease of -49.60%. That is a compound annual growth rate of -17.22%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	390.80M	-4.87%
May 16, 2024	410.80M	-2.28%
May 15, 2024	420.40M	1.84%
May 14, 2024	412.80M	-2.76%
May 13, 2024	424.50M	0.17%
May 10, 2024	423.80M	-9.43%
May 9, 2024	467.90M	5.43%
May 8, 2024	443.80M	-4.72%
May 7, 2024	465.80M	1.19%
May 6, 2024	460.30M	-0.45%
May 3, 2024	462.40M	4.83%
May 2, 2024	441.10M	-1.67%
May 1, 2024	448.60M	3.79%
Apr 30, 2024	432.20M	-0.32%
Apr 29, 2024	433.60M	2.43%
Apr 26, 2024	423.30M	-1.12%
Apr 25, 2024	428.10M	-3.54%
Apr 24, 2024	443.80M	-6.23%
Apr 23, 2024	473.30M	0.57%
Apr 22, 2024	470.60M	2.08%
Apr 19, 2024	461.00M	-2.74%
Apr 18, 2024	474.00M	0.57%
Apr 17, 2024	471.30M	0.60%
Apr 16, 2024	468.50M	-0.45%
Apr 15, 2024	470.60M	-7.42%

View and export this data all the way back to 2020. Sign Up Today.

Related Stocks

Company	Market Cap
Bioventus	408.50M
ADC Therapeutics	401.74M
Esperion Therapeutics	399.63M
Annexon	396.47M
Replimune Group	394.11M
ModivCare	389.09M
Contineum Therapeutics	388.27M
MultiPlan	385.63M